Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
VENTOLIN DISKUS GLAXOSMITHKLINE INC Actual shortage 200MCG Updated Report 2025-03-26 252627
ROCURONIUM BROMIDE INJECTION JUNO PHARMACEUTICALS CORP. Actual shortage 10MG Updated Report 2025-03-26 242057
DEPO-MEDROL (WITH PRESERVATIVE) 80 MG/ML PFIZER CANADA ULC Anticipated shortage 80MG New Report 2025-03-26 253471
0.9% SODIUM CHLORIDE IRRIGATION, USP BAXTER CORPORATION Anticipated shortage 900MG New Report 2025-03-26 253468
DEPO-MEDROL (WITH PRESERVATIVE) 20 MG/ML PFIZER CANADA ULC Anticipated shortage 20MG New Report 2025-03-26 253465
DEPO-MEDROL 80 MG/ML PFIZER CANADA ULC Actual shortage 80MG Updated Report 2025-03-26 242131
MARCAINE E PFIZER CANADA ULC Actual shortage 0.182MG 100MG Updated Report 2025-03-26 213236
DETROL LA BGP PHARMA ULC Actual shortage 2MG New Report 2025-03-26 253456
MYLAN-ATORVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2025-03-26 250646
SALBUTAMOL HFA SANIS HEALTH INC Actual shortage 100MCG Updated Report 2025-03-26 250070

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
NRA-TRAMADOL/ACET NORA PHARMA INC To be discontinued 37.5MG 325MG New Report 2025-03-25 253392
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 0.2% New Report 2025-03-24 253342
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 0.2% New Report 2025-03-24 253339
LATANOPROST OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 50MCG New Report 2025-03-24 253336
TEVA-FINGOLIMOD TEVA CANADA LIMITED Discontinued 0.5MG New Report 2025-03-20 253186